Abstract 3508
Background
Neoadjuvant chemotherapy (NAC) followed by surgery is regarded as a standard treatment for Stage II and III resectable thoracic esophageal squamous cell carcinoma (ESCC) in Japan. In general, therapeutic effect of NAC against the primary tumor is estimated microscopically with resected specimen after surgery. Then, this microscopic assessment is validated as surrogating survival. However, as this assessment needs resected specimen, therapeutic effect could not be evaluated before surgery. The aim of this study was to investigate whether therapeutic effects in imaging findings obtained by calculating tumor volume reduction could be a surrogating survival or not.
Methods
This retrospective study examined the patients who fulfilled the following criteria; (1) thoracic ESCC, (2) underwent esophagectomy following NAC between January 2011 and December 2015, and (3) clinical Stage II or III. Tumor volume was calculated by multiplying length and thickness in the lateral view of esophagography. The reduction rate of tumor volume was calculated as follow; ( pre NAC tumor volume – post NAC tumor volume) / pre NAC tumor volume . The cut off value of volume reduction ratio was determined as 50%, 60%, and 70% respectively. Patients were divided into an effective group and an ineffective group in each cut off value, and examined relationship with 3-year relapse-free survival (3yRFS). The hazard ratio (HR) for 3yRFS in each cut off value was estimated for selecting optimal cut off surrogating survival.
Results
In total, 93 patients were included in this study. 3yRFS of the effective group / ineffective group and HR of ineffective group for effective group in each cut off were 70.2% / 39.4% (HR = 0.469 [95% CI = 0.253 - 0.868], p = 0.0136) in 50%, 73.5% / 40.3% ( HR = 0.418 [95% CI = 0.216 - 0.809] , p = 0.00752) in 60%, and 80.4% / 42.8% (HR = 0.427 [95% CI = 0.199 - 0.916], p = 0.0243) in 70%.
Conclusions
Therapeutic effect of NAC evaluated by imaging finding was reflected in 3-year relapse free survival. Especially for optimal surrogate of 3yRFS, the optimal cut off point was 60% volume reduction after NAC.
Clinical trial identification
Legal entity responsible for the study
Kanagawa Cancer Center.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
T. Hayashi: Personal fee: MDS, Chugai, Ono. T. Yoshikawa: Personal fee: MDS, Chugai, Ono, Taiho. All other authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract